Veterinary practices are one of the cleanest acquisition targets in the lower middle market. Recurring revenue. Emotionally loyal clients. A succession crisis with no natural buyer lined up. According to the American Veterinary Medical Association, over 40% of practice-owning veterinarians are older than 55, and most lack a formal succession plan. That gap is where ETA operators find deals.
This is not theory. Corporate consolidators proved the model. Mars Veterinary Health, NVA, and PetVet have acquired thousands of practices since 2015 by buying at single-practice multiples and exiting at platform multiples. The arbitrage is real and repeatable. A search fund operator can execute the same playbook one practice at a time.
Here is how to think about it.
The valuation stack
Solo owner-operated practices with one DVM trade at 3.5x to 6x SDE (seller's discretionary earnings). Once you add a second DVM and the owner's production concentration drops below 50%, the multiple steps up. Multi-doctor groups at $500K to $1M in adjusted EBITDA trade at 8x to 12x from regional consolidators. Practices generating $1M-plus in adjusted EBITDA become PE-platform targets at 12x to 15x or higher.
Per CT Acquisitions' 2026 Veterinary M&A Multiples Report, the SVP/MVP platform merger in December 2024 closed at 17 to 18x EBITDA. That is the ceiling. It sets the exit logic for anyone building from the bottom.
The arbitrage is the thesis. Buy one practice at 5x EBITDA. Add a second DVM. Grow revenue per doctor to $700K-plus. Exit to a consolidator at 10x or higher. The spread between entry and exit multiple is where equity is created.
What makes a good target
Four factors determine whether a practice is worth pursuing.
Revenue per DVM. A full-time small-animal DVM should generate $600K to $900K in annual gross revenue. Below that range, something is wrong. Either the fee schedule is outdated, the market is saturated, or the doctor is working part-time. Find out which before you proceed.
Active client trends. Pull the active client count for the last 18 months. Growing is good. Flat is acceptable. Declining without explanation is a reason to pass. New client acquisition rate by month tells you more than the headline number.
Owner production concentration. If the selling DVM drives more than 70% of production, you are not buying a practice. You are buying a job, and the job leaves when the owner does. Budget a 15 to 25% revenue haircut in year one if the concentration is that high and no associate is in place.
Lease structure. Practices with less than five years remaining on the lease and no committed renewal option are deals with an expiration date built in. Landlord cooperation on assignment and renewal is non-negotiable before you submit a letter of intent. See our guide on structuring a letter of intent for business acquisitions for what to include at the LOI stage.
Running the due diligence
Financial diligence covers six workstreams: financial records, practice management reports, clinical compliance, real estate, insurance, and staff. The number that matters is adjusted EBITDA. Not net income. Not what the P&L says.
Start with reported net income. Add back owner compensation above market rate for the role, depreciation, personal expenses run through the practice, and one-time costs. Subtract deferred maintenance you will fund in year one. A practice showing $120K net income can normalize to $290K in adjusted EBITDA once owner add-backs are applied. Always verify the calculation with a vet-focused CPA before LOI.
Red flags worth walking away from:
- Owner DVM drives more than 70% of production with no associate in place
- P&L and tax returns do not reconcile without explanation
- Lease has less than five years remaining with no renewal commitment
- DEA controlled substance compliance issues in the last three years
- Equipment is 12-plus years old across the board with no capital plan
- Seller received and declined a corporate offer without a clear explanation
That last one matters. A seller who passed on an 11x EBITDA corporate offer to sell to you at 5x either has specific reasons worth understanding, or the corporate diligence found something the broker has not disclosed. Ask the question directly.
The ownership structure question
Many states require a licensed veterinarian to hold the practice license. Non-veterinarian operators use a management services organization model to own the economic interest while a licensed DVM retains the clinical license. This mirrors the dental DSO structure. Some states allow direct non-vet ownership. Others do not.
Check your state's Veterinary Practice Act before structuring the deal. This is not optional. Getting the structure wrong delays close and can void the license. A vet-focused attorney handles this for every deal; it is not a general business lawyer task.
Financing the acquisition
SBA 7(a) financing dominates veterinary practice acquisitions under $5M. Live Oak Bank, Bank of America Practice Solutions, and Wells Fargo Practice Finance underwrite roughly 80% of deals in this range per ctacquisitions.com's buyer data. Expect 10 to 15% buyer equity injection, 10-year amortization on goodwill and equipment, and floating rates at prime plus 2.5 to 3 percent.
The SBA requires 1.25x debt service coverage. A practice must generate at least $150K in adjusted EBITDA to support $120K in annual debt payments. Do the debt coverage math before you fall in love with a deal. Undercapitalized vet acquisitions fail at the bank, not at the negotiating table.
Per the SBA's current rules (SOP 50 10 8, effective June 1, 2025), a seller note can count toward up to half the required equity injection, but only if the note is placed on full standby for the entire loan term. Most sellers reject full-standby terms. Plan for the equity injection to come from cash.
Client retention is the deal
One number determines whether you succeed after close: client retention.
A selling DVM who exits immediately hands you a practice that retains roughly 65% of active clients in year one. A 12-month structured transition with the seller present part-time pushes retention to 92%. The difference at a $1.5M revenue practice is $405K in year-one revenue. Pay 5 to 10% more at close for a 12-month transition commitment. The math always supports it.
Wellness plans amplify this effect. A practice with high wellness plan penetration has recurring, predictable revenue regardless of who owns it. That is what makes a practice defensible post-acquisition. Making wellness plan enrollment a priority in the first 90 days is the highest-return operational move available to a new owner.
The exit path
Corporate consolidators are not just competitors. They are your exit. Mars Veterinary Health, NVA, AmeriVet, and Mission Pet Health are active buyers in most major markets. A 2-DVM practice generating $450K in adjusted EBITDA commands 7.5x from a regional consolidator per searchfundmarket.com's 2025 search fund acquisition guide. The same practice at $900K in adjusted EBITDA after two years of growth commands 10x or more from a PE-backed platform.
Multiple expansion and EBITDA growth together create the equity return. Veterinary is one of the few lower-middle-market verticals where a private buyer can build toward a credible PE exit within a 5 to 7 year hold. That is rare. Use it.
The operators who win in this space share one trait. They do not chase the headline multiple. They run the client retention math first, get the transition structure right, and let the EBITDA growth do the work.
Frequently Asked Questions
What EBITDA multiple should I expect to pay when buying a veterinary practice?
Solo owner-operated practices trade at 3.5x to 6x SDE for SBA-financed buyers. Multi-doctor groups with $500K to $1M in adjusted EBITDA trade at 8x to 12x from regional consolidators. The multiple is driven primarily by doctor count, EBITDA level, and how dependent the practice is on the selling veterinarian's production. PE-backed platforms pay 12x to 15x or higher for practices at $1M-plus in adjusted EBITDA.
Can a non-veterinarian own a veterinary practice?
In many states, yes, using a management services organization (MSO) structure. A licensed DVM retains the clinical practice license while the operator owns the management company that controls the economic interest. Some states allow direct non-vet ownership without the MSO structure. Check your state's Veterinary Practice Act before structuring the deal.
What is the typical timeline for a veterinary practice acquisition?
Solo buyers using SBA 7(a) financing should plan for 5 to 8 months from signed letter of intent to close. SBA underwriting takes 45 to 90 days. DEA controlled substance license transfer adds another 30 to 60 days. The post-close seller transition runs 6 to 24 months and is the most important variable for client retention.
What are the biggest due diligence risks when buying a veterinary practice?
Owner-dependence is the primary risk. If the selling DVM generates more than 70% of production, a sudden exit can trigger 25 to 35% revenue loss in year one. Other critical risks include DEA compliance issues, short lease terms without renewal options, equipment requiring immediate capital replacement, and unexplained gaps between P&L net income and tax returns.
